Higher price of mpox vaccine to pose key hurdle in Africa order talks

Q: How long will it take to read this news story?

The story "Higher price of mpox vaccine to pose key hurdle in Africa order talks" has 1100 words across 32 sentences, which will take approximately 5 - 10 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Higher price of mpox vaccine to pose key hurdle in Africa order talks" was covered 6 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 222 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22416336</li><li>URL: https://beamstart.com/news/higher-price-of-mpox-vaccine-17258481809737</li></ul>

Business Standard Logo Business Standard 6h ago

Higher price of mpox vaccine to pose key hurdle in Africa order talks - Business Standard

Quick Summary:

Chief Financial Officer Henrik Juuel told the Danish state broadcaster last week that Bavarian, when negotiating the price with Unicef, will take into account which countries will pay.

With few rivals for its vaccine in Africa, Bavarian is in the driver’s seat in setting the price for its jab.

Health organisations in Africa could negotiate a lower price if they make larger orders and commit to a vaccine programme of at least four to five years, Bowers said.